| Literature DB >> 30233288 |
Ana P S Dornellas1, Valter T Boldarine1, Amanda P Pedroso1, Lorenza O T Carvalho1, Iracema S de Andrade1, Tânia M Vulcani-Freitas1, Carla C C Dos Santos1, Cláudia M da Penha Oller do Nascimento1, Lila M Oyama1, Eliane B Ribeiro1.
Abstract
Menopause-induced changes may include increased incidence of both depression/anxiety and obesity. We hypothesized that behavioral changes that may develop after ovarian failure could be related to neurochemical and metabolic aspects affected by this condition and that high-fat intake may influence these associations. The present study investigated in rats the effects of ovariectomy, either alone or combined with high-fat diets enriched with either lard or fish-oil, on metabolic, behavioral and monoaminergic statuses, and on gene expression of neuropeptides and receptors involved in energy balance and mood regulation. Female rats had their ovaries removed and received either standard chow (OvxC) or high-fat diets enriched with either lard (OvxL) or fish-oil (OvxF) for 8 weeks. The Sham group received only chow diet. Ovariectomy increased feed efficiency and body weight gain and impaired glucose homeostasis and serotonin-induced hypophagia, effects either maintained or even accentuated by the lard diet but counteracted by the fish diet. The OvxL group developed obesity and hyperleptinemia. Regarding components of hypothalamic serotonergic system, both ovariectomy alone or combined with the fish diet increased 5-HT2C expression while the lard diet reduced 5-HT1B mRNA. Ovariectomy increased the anxiety index, as derived from the elevated plus maze test, while both high-fat groups showed normalization of this index. In the forced swimming test, ovariectomy allied to high-lard diet, but not to fish-oil diet, reduced the latency to immobility, indicating vulnerability to a depressive-like state. Linear regression analysis showed hippocampal AgRP to be negatively associated with the anxiety index and hypothalamic AgRP to be positively associated with the latency to immobility. These AgRp gene expression associations are indicative of a beneficial involvement of this neuropeptide on both depression and anxiety measures. The present findings demonstrate metabolic, neurochemical and behavioral alterations after ovaries removal and highlight a positive effect of high-fat feeding on the anxiety-like behavior shown by ovariectomized animals. Since the polyunsaturated ômega-3 intake (fish diet), unlike the saturated fat intake (lard diet), failed to induce deleterious metabolic or neurochemical consequences, further studies are needed focusing on the potential of this dietary component as an adjuvant anxiolytic agent after menopause.Entities:
Keywords: fish-oil; hippocampus; hypothalamus; lard; neuropeptides; serotonin
Year: 2018 PMID: 30233288 PMCID: PMC6129615 DOI: 10.3389/fnins.2018.00557
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 4.677
Body and serum parameters of Sham, OvxC, OvxL, and OvxF groups.
| Cumulative daily food intake (g/8 weeks) | 171.94 ± 14.27 ( | 163.12 ± 5.71 ( | 161.71 ± 2.81 ( | 148.00 ± 4.94 ( |
| Cumulative daily caloric intake (kcal/8 weeks) | 493.47 ± 40.95 ( | 468.15 ± 16.40 | 582.16 ± 10.11 | 532.78 ± 17.78 ( |
| Feed efficiency (g/Kcal/8 weeks) | 10.77 ± 0.86 ( | 16.95 ± 0.78 | 17.31 ± 0.80 | 12.88 ± 0.82 |
| Body weight gain (g/8 weeks) | 49.90 ± 1.96 ( | 70.51 ± 3.04 ( | 101.67 ± 3.67 | 70.18 ± 3.42 ( |
| Final body weight (g) | 247.91 ± 3.80 ( | 277.84 ± 4.98 | 307.16 ± 5.22 | 281.11 ± 3.86 |
| Adipose depots (g/100g) | 4.40 ± 0.24 ( | 4.77 ± 0.25 ( | 7.17 ± 0.27 | 4.12 ± 0.39 |
| Glucose (mg/dl) | 98.04 ± 2.38 ( | 116.53 ± 3.8 | 128.67 ± 2.66 | 128.28 ± 5.52 |
| Insulin (ng/ml) | 1.08 ± 0.07 ( | 1.19 ± 0.21 ( | 1.87 ± 0.43 | 0.74 ± 0.17 |
| Leptin (ng/ml) | 2.09 ± 0.49 ( | 4.30 ± 0.40 ( | 9.21 ± 1.27 | 2.50 ± 0.28 ( |
| Triglycerides (mg/dl) | 55.67 ± 7.45 ( | 67.71 ± 1.81 ( | 67.83 ± 7.21 ( | 32.25 ± 2.30 |
| Total cholesterol (mg/dl) | 63.32 ± 5.02 ( | 79.77 ± 3.87 ( | 90.16 ± 9.84 | 61.23 ± 2.39 |
Values are Mean ± SEM
p < 0.05 vs. Sham;
p < 0.05 vs. OvxC;
p < 0.05 vs. OvxL;
p < 0.05 vs. OvxF.
Catecholamines, serotonin and metabolites levels of the Sham OvxC, OvxL, and OvxF groups.
| 5-HT (pg/ml) | 607.81 ± 68.54 | 600.06 ± 25.32 | 558.73 ± 44.55 | 466.59 ± 34.95 |
| 5-HIAA (pg/ml) | 10.38 ± 0.36 | 10.09 ± 1.32 | 8.33 ± 0.26 | 8.96 ± 1.06 |
| Noradrenaline (pg/g) | 422.48 ± 26.06 | 419.45 ± 20.76 | 459.64 ± 8.98 | 412.70 ± 15.79 |
| Adrenaline (pg/g) | 12.17 ± 0.87 | 11.43 ± 0.59 | 14.21 ± 1.64 | 14.23 ± 1.59 |
| L-Dopa (pg/g) | 6.03 ± 1.22 | 6.20 ± 0.86 | 7.55 ± 0.88 | 6.036 ± 0.96 |
| Dopamine (pg/g) | 101.54 ± 10.29 | 102.85 ± 4.46 | 117.86 ± 11.14 | 110.50 ± 9.04 |
| 5-HIAA (pg/g) | 290.64 ± 43.54 | 317.66 ± 18.24 | 365.95 ± 43.96 | 420.43 ± 33.00 |
| 5-HT (pg/g) | 160.14 ± 18.29 | 192.93 ± 3.10 | 215.85 ± 23.11 | 180.17 ± 11.20 |
| 5-HIAA/5-HT | 1.83 ± 0.20 | 1.66 ± 0.12 | 1.72 ± 0.11 | 2.36 ± 0.22 |
| Noradrenaline (pg/g) | 56.04 ± 5.46 | 50.58 ± 4.37 | 47.58 ± 5.43 | 52.18 ± 2.25 |
| Adrenaline (pg/g) | 1.44 ± 0.15 | 1.46 ± 0.17 | 1.80 ± 0.38 | 1.68 ± 0.12 |
| L-Dopa (pg/g) | 0.95 ± 0.23 | 0.87 ± 015 | 1.27 ± 0.24 | 1.89 ± 0.23 |
| Dopamine (pg/g) | 3.30 ± 0.49 | 3.31 ± 0.63 | 3.40 ± 0.68 | 4.73 ± 1.04 |
| 5-HIAA (pg/g) | 147.31 ± 12.13 | 163.32 ± 8.33 | 166.04 ± 9.15 | 187.27 ± 7.56 |
| 5-HT (pg/g) | 89.84 ± 9.37 | 106.79 ± 5.28 | 103.63 ± 4.91 | 87.61 ± 5.77 |
| 5-HIAA/5HT | 1.69 ± 0.18 | 1.55 ± 0.10 | 1.60 ± 0.10 | 2.18 ± 0.21 |
Values are mean ± SEM n = 5–6.
p < 0.05 vs. Sham;
p < 0.05 vs. OvxC.
Hypothalamic gene expression of Sham, OvxC, OvxL, and OvxF animals.
| 5-HT1A | 1.01 ± 0.09 | 0.79 ± 0.09 | 0.68 ± 0.08 | 0.81 ± 0.03 |
| 5-HT1B | 1.00 ± 0.03 | 0.94 ± 0.07 | 0.71 ± 0.03 | 0.94 ± 0.06 |
| 5-HT2C | 1.01 ± 0.10 | 1.55 ± 0.13 | 1.26 ± 0.04 | 1.53 ± 0.12 |
| 5-HTT | 1.07 ± 0.15 | 0.98 ± 0.13 | 0.63 ± 0.11 | 1.06 ± 0.10 |
| POMC | 1.04 ± 0.19 | 1.41 ± 0.23 | 1.36 ± 0.10 | 1.02 ± 0.10 |
| CART | 1.03 ± 0.15 | 1.03 ± 0.11 | 1.19 ± 0.11 | 1.12 ± 0.09 |
| NPY | 1.00 ± 0.07 | 0.93 ± 0.05 | 0.89 ± 0.05 | 0.90 ± 0.06 |
| AgRP | 1.01 ± 0.11 | 0.76 ± 0.17 | 0.47 ± 0.04 | 0.51 ± 0.02 |
| AdipoR1 | 1.00 ± 0.03 | 1.09 ± 0.06 | 1.04 ± 0.02 | 1.10 ± 0.07 |
| AdipoR2 | 1.00 ± 0.01 | 0.86 ± 0.03 | 0.85 ± 0.05 | 0.79 ± 0.02 |
| ObR | 1.00 ± 0.06 | 1.07 ± 0.04 | 0.81 ± 0.11 | 0.90 ± 0.01 |
The mRNA levels were measured by RT-PCR and expression of the target genes was normalized against that of the Sham animals.
Values are mean ± SEM n = 5–6. The housekeeping gene β-actin mRNA was used to normalize the relative amounts of mRNA.
p < 0.05 vs. Sham.
Hippocampal gene expression of Sham, OvxC, OvxL, and OvxF animals.
| 5-HT1A | 1.02 ± 0.12 | 0.96 ± 0.15 | 0.91 ± 0.09 | 0.80 ± 0.08 |
| 5-HT1B | 1.04 ± 0.17 | 1.05 ± 0.06 | 1.16 ± 0.06 | 0.96 ± 0.10 |
| 5-HT2C | 1.00 ± 0.04 | 0.98 ± 0.16 | 1.50 ± 0.27 | 1.35 ± 0.19 |
| 5-HTT | 1.20 ± 0.40 | 0.79 ± 0.13 | 0.78 ± 0.18 | 0.76 ± 0.09 |
| POMC | 1.01 ± 0.10 | 1.43 ± 0.21 | 0.90 ± 0.09 | 1.36 ± 0.12 |
| CART | 1.07 ± 0.23 | 1.17 ± 0.21 | 1.15 ± 0.25 | 1.14 ± 0.22 |
| NPY | 1.00 ± 0.01 | 0.95 ± 0.09 | 1.09 ± 0.13 | 0.99 ± 0.06 |
| AgRP | 1.01 ± 0.10 | 0.88 ± 0.08 | 0.89 ± 0.09 | 1.12 ± 0.10 |
| AdipoR1 | 1.00 ± 0.01 | 0.94 ± 0.02 | 1.09 ± 0.08 | 1.14 ± 0.11 |
| AdipoR2 | 1.00 ± 0.04 | 0.83 ± 0.04 | 0.94 ± 0.10 | 0.77 ± 0.05 |
| ObR | 1.02 ± 0.12 | 1.06 ± 0.17 | 1.21 ± 0.20 | 1.02 ± 0.02 |
The mRNA levels were measured by RT-PCR and expression of the target genes was normalized against that of the Sham animals.
Values are mean ± SEM n = 5–6. The housekeeping gene β-actin mRNA was used to normalize the relative amounts of mRNA.
Figure 1Food intake of Sham (n = 4–6), OvxC (n = 4–5), OvxL (n = 4–5) and OvxF (n = 4–5) groups during the first and the second 12-h periods and the total 24-h period following the intracerebroventricular injection of vehicle (solid bars) or 300 μg of serotonin (dotted bars). αp < 0.05 vs. vehicle.
Figure 2Number of entries (A), distance (B), and percentage of time spent (C) in the open or closed arms, and anxiety index (D) during the elevated plus maze test of Sham (n = 12), OvxC (n = 8), OvxL (n = 9), and OvxF (n = 11) rats. *p < 0.05 vs. Sham; $p < 0.05 vs. OvxF.
Figure 3Swimming (A), climbing (B), immobility frequencies (C), and latency to immobility (D) of Sham (n = 14), OvxC (n = 8), OvxL (n = 12), and OvxF (n = 9) rats during the forced swim test. *p < 0.05 vs. Sham.
Pearson's correlation coefficients of the Sham, OvxC, OvxL, and OvxF groups.
| BW gain | −0.33 | −0.27 | −0.33 | −0.28 | 0.08 | −0.24 | −0.05 | −0.04 | −0.21 | −0.23 |
| Fat depots sum | −0.15 | −0.05 | −0.08 | −0.11 | 0.25 | −0.06 | 0.02 | 0.11 | −0.24 | −0.40 |
| 5-HT1B | −0.18 | −0.01 | −0.05 | 0.19 | 0.42 | 0.08 | 0.15 | 0.52 | −0.10 | −0.32 |
| 5-HT2C | −0.20 | 0.02 | −0.11 | 0.02 | −0.11 | −0.31 | 0.48 | 0.49 | −0.32 | −0.59 |
| SERT | −0.29 | 0.09 | −0.23 | 0.19 | 0.37 | −0.51 | 0.03 | 0.34 | 0.07 | −0.08 |
| AgRP | 0.36 | 0.14 | 0.28 | 0.00 | −0.83 | 0.06 | 0.48 | −0.26 | 0.12 | −0.01 |
| POMC | −0.08 | −0.07 | −0.16 | 0.14 | −0.18 | 0.00 | −0.09 | −0.30 | −0.28 | 0.61 |
| AdipoR1 | 0.25 | −0.03 | 0.28 | −0.20 | −0.23 | −0.35 | 0.67 | 0.05 | −0.44 | −0.28 |
| AdipoR2 | −0.04 | 0.55 | −0.09 | 0.17 | 0.22 | −0.48 | −0.17 | 0.15 | 0.09 | −0.24 |
| NPY | 0.08 | 0.56 | 0.06 | 0.60 | −0.25 | −0.25 | 0.04 | 0.17 | 0.11 | −0.03 |
| AgRP | 0.01 | 0.38 | −0.12 | 0.15 | 0.00 | −0.26 | −0.28 | −0.17 | 0.69 | 0.11 |
| AdipoR1 | 0.21 | 0.11 | 0.10 | 0.05 | −0.25 | −0.03 | 0.17 | −0.41 | −0.50 | 0.41 |
| AdipoR2 | 0.11 | 0.53 | −0.05 | 0.21 | 0.00 | −0.40 | −0.23 | −0.10 | 0.45 | −0.08 |
Pearson's correlation coefficients between behavioral body adiposity and gene expression parameters (n = 15–16).
EOA, number of entries in open arms; ECA, number of entries in closed arms; DOA, distance traveled in open arms; DCA, distance traveled in closed arms; AI, anxiety index; HD, headdipping; FI, frequency of immobility; LI, latency of immobility; FS, frequency of swimming.
p < 0.05.
Linear regression models for predictors of behavioral parameters.
| AgRP | −0.34 | 0.06 | 8.11−5 |
| Intercept | 0.95 | 0.06 | 3.72−10 |
| 5-HT1B
| 11.46 | 4.99 | 0.037 |
| Intercept | 30.80 | 5.38 | 5.27−5 |
| AgRP | 58.81 | 17.15 | 0.004 |
| Intercept | 11.97 | 12.06 | 0.33 |
hpc, hippocampus; hpt, hypothalamus.